Cannabidiol (CBD) is a natural plant cannabinoid or phytocannabinoid that can be extracted from Cannabis Sativa L. It is one of over 100 known cannabinoids contained in cannabis. Cannabinoids are a diverse set of chemical compounds that bind to special receptors in the human body. Unlike the widely known cannabinoid Tetrahydrocannabinol (THC), CBD does not have psychoactive or euphoric effects. Further, CBD has the ability to reduce those effects in high CBD to THC ratios.
Cannabinoids interact with our bodies via the Endogenous Cannabinoid System (ECS) more commonly known as the Endocannabinoid System. The ECS is a biochemical control system within our bodies that includes specialized receptors configured to accept certain cannabinoids. It is also the most important physiologic system for establishing and maintaining homeostasis. Cannabinoids that are produced by the body or endocannabinoids and their receptors are found throughout the human body giving them a wide variety of functions.
CBD has been clinically proven to greatly reduce and often end seizures in epileptic patients including children. CBD works by helping lower excessive electrical and chemical activity in the brain.
CBD has been proven to reduce the side effects of chemotherapy and pain associated with cancer. Recent animal studies show that CBD and other cannabinoids demonstrate the ability to slow the growth and even kill some cancer cells.
CBD has anti-inflammatory and analgesic properties that make it ideal for pain management. Previous and ongoing research show promise for CBD as a treatment for chronic pain, neuropathic pain, multiple sclerosis, arthritis, rheumatoid arthritis, fibromyalgia, migraines and spinal cord injuries.
CBD has shown success in the treatment of schizophrenia, anxiety, PTSD, autism, stress and sleep disorders. CBD has antipsychotic properties, which allows it to counteract some of THC’s adverse effects. CBD has proven to reduce both behavioral and physiological (e.g. heart rate) in measures of stress and anxiety.
CBD and other cannabinoids show great potential for the management of several gastrointestinal disorders such as Inflammatory Bowel Disease, Irritable Bowel Syndrome, nausea, Crohn’s Disease, and decreased appetite. Although more research is warranted, most patients already receiving treatment are experiencing positive results.
CBD has well documented anti-inflammatory properties. These properties could treat the chronic inflammation associated with insulin resistance (i.e. Type 2 Diabetes). A recent study also showed CBD interfered in the onset of type 1 diabetes in mice.
CBD has been shown to reduce cravings and anxiety in patients struggling with addiction. Additionally, CBD is a neuroprotectant that can lessen damage to the brain caused by neurotoxicity that is common in long-term addicts and alcoholics.